Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728571 · ClinicalTrials.gov registry record · NA
LungVITamin D and OmegA-3 Trial (lungVITAL)
A NA study of Asthma and COPD, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 25,871
- Enrollment target
- 1
- Study location
NCT01728571 is a NA study of Asthma and COPD that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 25,871 participants, above the 1,494-participant average among 374 other Asthma trials with a reported enrollment target (1632% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01728571, a NA study of Asthma and COPD, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25,871 participants
- Enrollment target
- 1
- Study location
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL and will examine whether vitamin D or fish oil reduces respiratory morbidity, including COPD and asthma exacerbations, the risk of pneumonia, and airflow obstruction/decline of pulmonary function; and whether either of these interventions improves asthma control.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Fish oil placebo
- DIETARY_SUPPLEMENT fish oil
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,871 participants |
| Start Date | 2010-07 |
| Est. Completion | 2025-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01728571
The ClinicalTrials.gov registry entry for NCT01728571 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25,871 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,494-participant average among 374 other Asthma trials with a reported enrollment target (1632% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 4 interventions - of which Vitamin D3 is the first listed.
NCT01728571 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01728571 about?
NCT01728571 is a clinical study titled "LungVITamin D and OmegA-3 Trial (lungVITAL)". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart dis...
What is the current status of trial NCT01728571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25,871 participants. The study started on 2010-07. Estimated completion is 2025-02.
What conditions does trial NCT01728571 study?
This clinical trial studies the following conditions: Asthma, COPD, Pneumonia, Pulmonary Function.
What interventions are being tested in trial NCT01728571?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), fish oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01728571?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01728571 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.